{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:28:47Z","timestamp":1763627327002,"version":"3.45.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016321","name":"Lanzhou University First Hospital","doi-asserted-by":"publisher","award":["ldyyyn2020-60"],"award-info":[{"award-number":["ldyyyn2020-60"]}],"id":[{"id":"10.13039\/501100016321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001066"],"award-info":[{"award-number":["82001066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jormas.2024.102146","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:24:22Z","timestamp":1731673462000},"page":"102146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Network pharmacology and in vitro experiments reveal the potential therapeutic effects of Scrophularia ningpoensis Hemsl in the treatment of ameloblastoma"],"prefix":"10.1016","volume":"126","author":[{"given":"Jing-Rui","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Fu","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-2086","authenticated-orcid":false,"given":"Qi-Wen","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jormas.2024.102146_bib0001","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/odi.12646","article-title":"Ameloblastoma: current etiopathological concepts and management","volume":"24","author":"Effiom","year":"2018","journal-title":"Oral Dis"},{"issue":"2","key":"10.1016\/j.jormas.2024.102146_bib0002","first-page":"168","article-title":"The world health organization classification of odontogenic lesions: a summary of the changes of the 2022 (5th) edition","volume":"38","author":"Soluk-Tekkesin","year":"2022","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.jormas.2024.102146_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106651","article-title":"Recurrence and malignant risk of ameloblastoma: a demographic study of 1626 cases from east China","volume":"148","author":"Liu","year":"2024","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.jormas.2024.102146_bib0004","first-page":"e70","article-title":"Surgical management of ameloblastoma. Review of literature","volume":"11","author":"Neagu","year":"2019","journal-title":"J Clin Exp Dent"},{"issue":"4","key":"10.1016\/j.jormas.2024.102146_bib0005","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s12663-023-01998-1","article-title":"The colossal mandibular ameloblastoma: surgical challenges and current perspectives of management","volume":"22","author":"Das","year":"2023","journal-title":"J Maxillofac Oral Surg"},{"issue":"3","key":"10.1016\/j.jormas.2024.102146_bib0006","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4314\/gmj.v48i3.8","article-title":"A review of 156 odontogenic tumours in Calabar, Nigeria","volume":"48","author":"Anyanechi","year":"2014","journal-title":"Ghana Med J"},{"issue":"1","key":"10.1016\/j.jormas.2024.102146_bib0007","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.oooo.2015.12.016","article-title":"BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response","volume":"122","author":"Tan","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"issue":"9","key":"10.1016\/j.jormas.2024.102146_bib0008","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/diagnostics14090910","article-title":"Frequency and demographic analysis of odontogenic tumors in three tertiary institutions: an 11-year retrospective study","volume":"14","author":"Almazyad","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"10.1016\/j.jormas.2024.102146_bib0009","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1007\/s00405-016-3899-3","article-title":"Treatment of ameloblastoma and ameloblastic carcinoma with radiotherapy","volume":"273","author":"Kennedy","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.jormas.2024.102146_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tripleo.2010.01.024","article-title":"Are we on the brink of nonsurgical treatment for ameloblastoma?","volume":"110","author":"Sauk","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"10.1016\/j.jormas.2024.102146_bib0011","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/path.4317","article-title":"High frequency of BRAF V600E mutations in ameloblastoma","volume":"232","author":"Kurppa","year":"2014","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.jormas.2024.102146_bib0012","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1186\/s12885-018-4802-y","article-title":"Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation","volume":"18","author":"Fernandes","year":"2018","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.jormas.2024.102146_bib0013","first-page":"ZE10","article-title":"Sonic hedgehog signalling pathway and ameloblastoma - a review","volume":"9","author":"Mishra","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jormas.2024.102146_bib0014","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3389\/fphar.2018.01186","article-title":"Pharmacokinetics, bioavailability, and tissue distribution study of angoroside C and its metabolite ferulic acid in rat using UPLC-MS\/MS","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jormas.2024.102146_bib0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jpp\/rgaa036","article-title":"Scrophularia ningpoensis Hemsl: a review of its phytochemistry, pharmacology, quality control and pharmacokinetics","volume":"73","author":"Zhang","year":"2021","journal-title":"J Pharm Pharmacol"},{"issue":"11","key":"10.1016\/j.jormas.2024.102146_bib0016","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/10286020.2018.1513919","article-title":"Two new compounds from the roots of Scrophularia ningpoensis and their anti-inflammatory activities","volume":"21","author":"Huo","year":"2019","journal-title":"J Asian Nat Prod Res"},{"issue":"9","key":"10.1016\/j.jormas.2024.102146_bib0017","first-page":"1597","article-title":"[Chemical constituents of Scrophularia ningpoensis root]","volume":"37","author":"Xue","year":"2014","journal-title":"Zhong Yao Cai"},{"key":"10.1016\/j.jormas.2024.102146_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8899762","article-title":"Polysaccharides of Scrophularia ningpoensis Hemsl.: extraction, antioxidant, and anti-inflammatory evaluation","volume":"2020","author":"Wang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"10.1016\/j.jormas.2024.102146_bib0019","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/ph5020189","article-title":"Effects of Scrophularia ningpoensis Hemsl. on inhibition of proliferation, apoptosis induction and NF-\u03baB signaling of immortalized and cancer cell lines","volume":"5","author":"Shen","year":"2012","journal-title":"Pharmaceuticals (Basel)"},{"issue":"16","key":"10.1016\/j.jormas.2024.102146_bib0020","first-page":"4302","article-title":"Chemical constituents, pharmacological activities, processing and clinical application of traditional Chinese medicine Scrophulariae Radix: a review","volume":"48","author":"Liu","year":"2023","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"1","key":"10.1016\/j.jormas.2024.102146_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.path.2016.10.006","article-title":"Odontogenic cysts and neoplasms","volume":"10","author":"Bilodeau","year":"2017","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"10.1016\/j.jormas.2024.102146_bib0022","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.4317\/medoral.18006","article-title":"Histopathology of ameloblastoma of the jaws; some critical observations based on a 40 years single institution experience","volume":"17","author":"Hertog","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal."},{"issue":"2","key":"10.1016\/j.jormas.2024.102146_bib0023","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MOO.0000000000000238","article-title":"Ameloblastomas of the mandible and maxilla","volume":"24","author":"Parmar","year":"2016","journal-title":"Curr Opin Otolaryngol Head Neck Surg."},{"issue":"7","key":"10.1016\/j.jormas.2024.102146_bib0024","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/odi.13014","article-title":"Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta-analysis","volume":"25","author":"Hendra","year":"2019","journal-title":"Oral Dis"},{"issue":"7","key":"10.1016\/j.jormas.2024.102146_bib0025","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00405-015-3631-8","article-title":"Ameloblastoma: a clinical review and trends in management","volume":"273","author":"McClary","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"Suppl 16","key":"10.1016\/j.jormas.2024.102146_bib0026","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1200\/JCO.2022.40.16_suppl.3149","article-title":"BRAF-targeted therapy for locally advanced ameloblastoma of the mandible: a potential neoadjuvant strategy","volume":"40","author":"Grynberg","year":"2022","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jormas.2024.102146_bib0027","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/000348940311201207","article-title":"Ameloblastoma revisited","volume":"112","author":"Junquera","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"9","key":"10.1016\/j.jormas.2024.102146_bib0028","first-page":"1529","article-title":"Recurrent tumours of ameloblastoma: clinicopathologic features and diagnostic outcome","volume":"25","author":"Nwoga","year":"2022","journal-title":"Niger J Clin Pract"},{"issue":"4","key":"10.1016\/j.jormas.2024.102146_bib0029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jop.12839","article-title":"The importance of BRAF-V600E mutation to ameloblastoma metabolism","volume":"48","author":"Duarte-Andrade","year":"2019","journal-title":"J Oral Pathol Med"},{"issue":"3S","key":"10.1016\/j.jormas.2024.102146_bib0030","article-title":"Exploiting BRAF mutations in the therapeutic approach towards oral and maxillofacial tumors","volume":"125","author":"Yi","year":"2024","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2024.102146_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113688","article-title":"Pharmacology, phytochemistry, and traditional uses of Scrophularia ningpoensis Hemsl","volume":"269","author":"Ren","year":"2021","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.jormas.2024.102146_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5757","article-title":"A metabolism-based study of the mechanism of action of Scrophularia ningpoensis Hemsl. on nephrogenic edema","volume":"38","author":"Dong","year":"2024","journal-title":"Biomed Chromatogr"},{"issue":"13","key":"10.1016\/j.jormas.2024.102146_bib0033","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3390\/molecules25133021","article-title":"Anti-hepatocellular-cancer activity exerted by \u03b2-sitosterol and \u03b2-sitosterol-glucoside from Indigofera zollingeriana Miq","volume":"25","author":"Vo","year":"2020","journal-title":"Molecules"},{"issue":"35","key":"10.1016\/j.jormas.2024.102146_bib0034","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1021\/acs.jafc.9b02730","article-title":"Effects of \u03b2-sitosterol from corn silk on TGF-\u03b21-induced epithelial-mesenchymal transition in lung alveolar epithelial cells","volume":"67","author":"Park","year":"2019","journal-title":"J Agric Food Chem"},{"issue":"2-3","key":"10.1016\/j.jormas.2024.102146_bib0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-2999(99)00846-8","article-title":"Anti-inflammatory glycoterpenoids from Scrophularia auriculata","volume":"389","author":"Giner","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jormas.2024.102146_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105313","article-title":"Sugiol, a diterpenoid: therapeutic actions and molecular pathways involved","volume":"163","author":"Bajpai","year":"2021","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.jormas.2024.102146_bib0037","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcp.2015.06.033","article-title":"Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells","volume":"97","author":"Jung","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.jormas.2024.102146_bib0038","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.31374","article-title":"Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells","volume":"143","author":"Zhou","year":"2018","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.jormas.2024.102146_bib0039","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nm.2385","article-title":"Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy","volume":"17","author":"Huang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jormas.2024.102146_bib0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2016.10.042","article-title":"Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism","volume":"385","author":"Feng","year":"2017","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.jormas.2024.102146_bib0041","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1368-8375(00)00079-8","article-title":"Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma","volume":"37","author":"Sandra","year":"2001","journal-title":"Oral Oncol"},{"issue":"12","key":"10.1016\/j.jormas.2024.102146_bib0042","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"7466","key":"10.1016\/j.jormas.2024.102146_bib0043","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12441","article-title":"Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers","volume":"501","author":"Hatzivassiliou","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jormas.2024.102146_bib0044","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41389-019-0119-1","article-title":"Most canine ameloblastomas harbor HRAS mutations, providing a novel large-animal model of RAS-driven cancer","volume":"8","author":"Saffari","year":"2019","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.jormas.2024.102146_bib0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-0714.2009.00827.x","article-title":"Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma","volume":"39","author":"Zhang","year":"2010","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"10.1016\/j.jormas.2024.102146_bib0046","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1215\/15228517-2008-035","article-title":"Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets","volume":"10","author":"Baryawno","year":"2008","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.jormas.2024.102146_bib0047","first-page":"434","article-title":"Prostaglandin E2 and cancer: insight into tumor progression and immunity","volume":"9","author":"Finetti","year":"2020","journal-title":"Biology (Basel)"},{"issue":"11","key":"10.1016\/j.jormas.2024.102146_bib0048","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3390\/cancers16112029","article-title":"Cysteamine suppresses cancer cell invasion and migration in glioblastoma through inhibition of matrix metalloproteinase activity","volume":"16","author":"Jung","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jormas.2024.102146_bib0049","doi-asserted-by":"crossref","DOI":"10.1002\/iub.2858","article-title":"COX-2\/PTGS2-targeted herbal-derived oligonucleotide drug HQi-sRNA-2 was effective in spontaneous mouse lung cancer model","author":"Lin","year":"2024","journal-title":"IUBMB Life"}],"container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878552400435X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878552400435X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:25:01Z","timestamp":1763627101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246878552400435X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S246878552400435X"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2024.102146","relation":{},"ISSN":["2468-7855"],"issn-type":[{"type":"print","value":"2468-7855"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network pharmacology and in vitro experiments reveal the potential therapeutic effects of Scrophularia ningpoensis Hemsl in the treatment of ameloblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2024.102146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102146"}}